23 July 2025
Notice of Meeting and proxy form
Notice is hereby given that the 2025 Annual Shareholder Meeting of BLIS Technologies Limited will be held on Thursday 21 August 2025 at 11.00am at Tūhura Otago Museum, The Hutton Theatre, 419 Great King Street, Dunedin and online at www.virtualmeeting.co.nz/blt25 (registrations will open at 10.30am).
Attached are the following documents which are being sent to shareholders today:
- Notice of Meeting
- Voting/Proxy Form
Ends
For further information, please contact: 
Richard Wingham
Chief Financial Officer
Blis Technologies Limited
+64 21 284 0446
About BLIS Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics.
BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz.
Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 
Facebook: @BLISProbiotics 
        Market leader Fisher & Paykel Healthcare was up 25c.
From wannabe Google challenger to now selling off its last business to escape debt.
                    Looks to grow at pace of economy, invests in business.
                    To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details